corporary

ALGENSCRIBE

Active
SIREN 922650718 VAT number FR33922650718

Business purpose.

Le développement de tous produits et technologies utilisant des modules d'édition du génome nucléaire et mitochondrial ainsi que des systèmes de vectorisation et/ou délivrance dans les domaines des outils de recherche en biotechnologie, de la bioproduction, de la thérapie de pathologies humaines, du diagnostic de pathologies humaines et des thérapies et diagnostics vétérinaires.

Identity

Legal form
SAS, simplified joint-stock company
Activity
Research and experimental development on biotechnology (72.11Z)
Sector
Scientific research and development
Headcount
1 to 2 employees
Created
21 Dec 2022
Share capital
37,648.00 EUR
Registered with the trade register
30 Dec 2022
Financial year end
31/12
Establishments
1

Directors

Other companies at the same address

23 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

68 / 100 B

Confidence: low · computed on the financial year ended 31 Dec 2024

Equity to assets (54.2 %)
19.6 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity (591.5 %)
16.4 out of 20
Debt (69.0 %)
8.5 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

88 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (3.9 years)
7.8 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Financial year Revenue Change EBITDA Net income
31 Dec 2024 0 € first year on record 0 € -119,204 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.

    IDCC 0176 · repealed · 1 establishment · declared in August 2026

Legal notices

  • Filing of accounts 7 May 2026
    Court :
    Greffe du Tribunal de Commerce de nice
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2025

    BODACC C n 20260087, annonce n 277 · Proof of publication (PDF)

  • Amendment 23 Nov 2025
    Court :
    Greffe du Tribunal de Commerce de Nice
    Amendment :
    Modification survenue sur le capital.

    BODACC B n 20250225, annonce n 160 · Proof of publication (PDF)

  • Amendment 3 Aug 2025
    Court :
    Greffe du Tribunal de Commerce de Nice
    Amendment :
    Modification survenue sur le capital.

    BODACC B n 20250147, annonce n 146 · Proof of publication (PDF)

  • Filing of accounts 1 Aug 2025
    Court :
    Greffe du Tribunal de Commerce de nice
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250146, annonce n 473 · Proof of publication (PDF)

  • Amendment 6 Feb 2025
    Court :
    Greffe du Tribunal de Commerce de Nice
    Amendment :
    Modification survenue sur le capital.

    BODACC B n 20250026, annonce n 219 · Proof of publication (PDF)

  • Filing of accounts 23 Jan 2025
    Court :
    Greffe du Tribunal de Commerce de nice
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2023

    BODACC C n 20250016, annonce n 628 · Proof of publication (PDF)

  • Amendment 5 Jul 2023
    Court :
    Greffe du Tribunal de Commerce de Nice
    Amendment :
    Modification survenue sur le capital.

    BODACC B n 20230128, annonce n 68 · Proof of publication (PDF)

Annual accounts as PDF →

Filings and accounts

  • Formality 20 Nov 2025
  • Formality 30 Jul 2025
  • Formality 4 Feb 2025

Change history

  • officer_appointed (empty) → President de SAS 9 Oct 2026
  • capital 30327.00 → 25581.00 3 Oct 2026
  • capital 28614.00 → 30327.00 2 Oct 2026
  • capital 37648.00 → 28614.00 2 Oct 2026
  • registered_address (empty) → Ceei Nice Côte D'Azur 06200 Nice 1 Oct 2026
  • capital (empty) → 37648.00 1 Oct 2026

Frequently asked questions about ALGENSCRIBE

What is the SIREN number of ALGENSCRIBE?
The SIREN number of ALGENSCRIBE is 922650718. Its intra-community VAT number is FR33922650718.
Where is the head office of ALGENSCRIBE?
Head office address: 61 AVENUE SIMONE VEIL, 06200 NICE.
When was ALGENSCRIBE founded?
ALGENSCRIBE was founded on 21 Dec 2022.
What does ALGENSCRIBE do?
Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
Who runs ALGENSCRIBE?
The officer listed in the register is FREDERIC GILLES ZAMPATTI (President de SAS).
What is the revenue of ALGENSCRIBE?
The latest published revenue is 0 €, for the 2024 financial year.
How many employees does ALGENSCRIBE have?
The declared headcount is 1 to 2 employees. Insee data for 2024.
Is ALGENSCRIBE subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data